Invesco Dynamic Biotechnology & Genome ETF: (PBE)
(Delayed Data from NYSE) As of Apr 9, 2021 04:00 PM ET
$72.94 USD
-0.70 (-0.95%)
Volume: 5,658
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
Zacks Rank | Definition |
---|---|
1 | Strong Buy |
2 | Buy |
3 | Hold |
4 | Sell |
5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Quote Details
Previous Close | 73.64 |
Open | 73.12 |
Bid | 72.51 |
Ask | 74.27 |
Day Low-High | 72.66-73.12 |
52wk Low-High | 48.12-84.86 |
Volume | 5,658 |
NAV (month end) | 73.79 |
Premium (+)/Discount (-) (month end) | -0.15 |
ETF Expense Ratio
Expense Ratio | 0.58% |
Dividend (Yield) | $0.00 (0.00%) |
Issuer | INVESCO |
Benchmark for PBE
DYNAMIC BIOTECH & GENOME INTELLIDEX INDX
The Dynamic Biotech & Genome Intellidex Index seeks to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value.
Fund Summary for PBE
INVESCO DYNMC BIOTECHNOLOGY & GENOME ETF
The Invesco Dynamic Biotechnology & Genome ETF is based on the Dynamic Biotech & Genome Intellidex Index.